Clinical Research Directory
Browse clinical research sites, groups, and studies.
Post Market Clinical Follow-Up KeriFuse®
Sponsor: Keri Medical SA
Summary
The general objective of this study is to evaluate the performances and the safety related to the KeriFuse® intramedullary arthrodesis implant and associated instrumentation used in accordance with their approved labelling and instruction for use. Performance and safety of KeriFuse® intramedullary arthrodesis implant will be established on short and middle-terms in regards to the implant life-cycle.
Official title: Effectiveness and Safety of the KeriFuse® Intramedullary Arthrodesis Implant and Associated Instruments in the Treatment of IP or DIP Arthritis: a Post Market Clinical Follow-up.
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
97
Start Date
2022-07-05
Completion Date
2027-03
Last Updated
2025-09-11
Healthy Volunteers
No
Conditions
Interventions
KeriFuse®
The intramedullary arthrodesis Implant (KeriFuse®) is indicated for consolidation or bone fusion (arthrodesis) of degraded or arthritic distal interphalangeal (DIP) of hand digits or interphalangeal (IP) joint of the hand thumb.
Locations (6)
Centre de la main du Pays d'Aix
Aix-en-Provence, France
Clinique de la Chataigneraie
Beaumont, France
Centre Ostéo Articulaire Fleming
Bourgoin, France
Clinique Saint François
Nice, France
Clinique Mutualiste Catalane
Perpignan, France
Clinique du Parc
Périgueux, France